SHOWS STRONG SALES IN JANUARY AND CONTINUED GROWTH IN FEBRUARY.
IRVINE, CA, Feb. 19, 2014 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that Mesa Pharmacy Inc. ("Mesa") has executed a marketing agreement with Trestles Pain Specialists LLC of San Juan Capistrano, California to expand sales within California and, eventually, in other states. Physician groups and industrial medical clinics in the central valley of California and other new locations throughout California will now be using the alternative transdermal medications Mesa compounds.
FDA Reclassification of Hydrocodone to Schedule II Could Boost Sales.
PALO ALTO, CA, Dec. 5, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that work on the name change to Praxsyn Corporation is nearing completion and that the Company expects to be able to file a request with FINRA early next week along with filing the necessary filings and disclosures with the SEC and the State of Illinois.
Palo Alto, CA – October 17, 2013 - The PAWS Pet Company, Inc. (OTCQB:PAWS), is pleased to announce that the three short-term convertible notes that were negotiated with Asher Enterprises, Inc. in 2012 have been paid in full. The final interest payment on the last of those notes was paid today.
The PAWS Pet Company, Inc. (OTCQB:PAWS), today announced that as part of its ongoing transition from the pet space to the pharmaceutical space the Company has begun the process of changing its name to Praxsyn Corporation and will also change its state of incorporation from from Illinois to Nevada.